Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'indexation
PER : Périodiques |
Ouvrages de la bibliothèque en indexation PER (24507)
Faire une suggestion Affiner la recherche
A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism / Antonio Y. HARDAN in Journal of Child Psychology and Psychiatry, 56-8 (August 2015)
[article]
Titre : A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism Type de document : Texte imprimé et/ou numérique Auteurs : Antonio Y. HARDAN, Auteur ; Grace W. GENGOUX, Auteur ; Kari L. BERQUIST, Auteur ; Robin A. LIBOVE, Auteur ; Christina M. ARDEL, Auteur ; Jennifer PHILLIPS, Auteur ; Thomas W. FRAZIER, Auteur ; Mendy B. MINJAREZ, Auteur Article en page(s) : p.884-892 Langues : Anglais (eng) Mots-clés : Language deficits treatment fidelity group parent training social communication naturalistic developmental behavior intervention Index. décimale : PER Périodiques Résumé : Background With rates of autism diagnosis continuing to rise, there is an urgent need for effective and efficient service delivery models. Pivotal Response Treatment (PRT) is considered an established treatment for autism spectrum disorder (ASD); however, there have been few well-controlled studies with adequate sample size. The aim of this study was to conduct a randomized controlled trial to evaluate PRT parent training group (PRTG) for targeting language deficits in young children with ASD. Methods Fifty-three children with autism and significant language delay between 2 and 6 years old were randomized to PRTG (N = 27) or psychoeducation group (PEG; N = 26) for 12 weeks. The PRTG taught parents behavioral techniques to facilitate language development. The PEG taught general information about ASD (clinical trial NCT01881750; http://www.clinicaltrials.gov). Results Analysis of child utterances during the structured laboratory observation (primary outcome) indicated that, compared with children in the PEG, children in the PRTG demonstrated greater improvement in frequency of utterances (F(2, 43) = 3.53, p = .038, d = 0.42). Results indicated that parents were able to learn PRT in a group format, as the majority of parents in the PRTG (84%) met fidelity of implementation criteria after 12 weeks. Children also demonstrated greater improvement in adaptive communication skills (Vineland-II) following PRTG and baseline Mullen visual reception scores predicted treatment response to PRTG. Conclusions This is the first randomized controlled trial of group-delivered PRT and one of the largest experimental investigations of the PRT model to date. The findings suggest that specific instruction in PRT results in greater skill acquisition for both parents and children, especially in functional and adaptive communication skills. Further research in PRT is warranted to replicate the observed results and address other core ASD symptoms. En ligne : http://dx.doi.org/10.1111/jcpp.12354 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=263
in Journal of Child Psychology and Psychiatry > 56-8 (August 2015) . - p.884-892[article] A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism [Texte imprimé et/ou numérique] / Antonio Y. HARDAN, Auteur ; Grace W. GENGOUX, Auteur ; Kari L. BERQUIST, Auteur ; Robin A. LIBOVE, Auteur ; Christina M. ARDEL, Auteur ; Jennifer PHILLIPS, Auteur ; Thomas W. FRAZIER, Auteur ; Mendy B. MINJAREZ, Auteur . - p.884-892.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 56-8 (August 2015) . - p.884-892
Mots-clés : Language deficits treatment fidelity group parent training social communication naturalistic developmental behavior intervention Index. décimale : PER Périodiques Résumé : Background With rates of autism diagnosis continuing to rise, there is an urgent need for effective and efficient service delivery models. Pivotal Response Treatment (PRT) is considered an established treatment for autism spectrum disorder (ASD); however, there have been few well-controlled studies with adequate sample size. The aim of this study was to conduct a randomized controlled trial to evaluate PRT parent training group (PRTG) for targeting language deficits in young children with ASD. Methods Fifty-three children with autism and significant language delay between 2 and 6 years old were randomized to PRTG (N = 27) or psychoeducation group (PEG; N = 26) for 12 weeks. The PRTG taught parents behavioral techniques to facilitate language development. The PEG taught general information about ASD (clinical trial NCT01881750; http://www.clinicaltrials.gov). Results Analysis of child utterances during the structured laboratory observation (primary outcome) indicated that, compared with children in the PEG, children in the PRTG demonstrated greater improvement in frequency of utterances (F(2, 43) = 3.53, p = .038, d = 0.42). Results indicated that parents were able to learn PRT in a group format, as the majority of parents in the PRTG (84%) met fidelity of implementation criteria after 12 weeks. Children also demonstrated greater improvement in adaptive communication skills (Vineland-II) following PRTG and baseline Mullen visual reception scores predicted treatment response to PRTG. Conclusions This is the first randomized controlled trial of group-delivered PRT and one of the largest experimental investigations of the PRT model to date. The findings suggest that specific instruction in PRT results in greater skill acquisition for both parents and children, especially in functional and adaptive communication skills. Further research in PRT is warranted to replicate the observed results and address other core ASD symptoms. En ligne : http://dx.doi.org/10.1111/jcpp.12354 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=263 A randomized controlled trial of preschool-based joint attention intervention for children with autism / Anett KAALE in Journal of Child Psychology and Psychiatry, 53-1 (January 2012)
[article]
Titre : A randomized controlled trial of preschool-based joint attention intervention for children with autism Type de document : Texte imprimé et/ou numérique Auteurs : Anett KAALE, Auteur ; Lars SMITH, Auteur ; Eili SPONHEIM, Auteur Année de publication : 2012 Article en page(s) : p.97-105 Langues : Anglais (eng) Mots-clés : Autism joint attention joint engagement intervention preschool randomized controlled trial Index. décimale : PER Périodiques Résumé : Background: Deficits in joint attention (JA) and joint engagement (JE) represent a core problem in young children with autism as these affect language and social development. Studies of parent-mediated and specialist-mediated JA-intervention suggest that such intervention may be effective. However, there is little knowledge about the success of the intervention when done in preschools. Aim: Assess the effects of a preschool-based JA-intervention. Methods: 61 children (48 males) with autistic disorder (29–60 months) were randomized to either 8 weeks of JA-intervention, in addition to their preschool programs (n = 34), or to preschool programs only (n = 27). The intervention was done by preschool teachers with weekly supervision by trained counselors from Child and Adolescent Mental Health Clinics (CAMHC). Changes in JA and JE were measured by blinded independent testers using Early Social Communication Scale (ESCS) and video taped preschool teacher–child and mother–child play at baseline and post-intervention. Clinical trials registration: Clinicaltrials.gov: NCT00378157. Results: Intention-to-treat analysis showed significant difference between the intervention and the control group, with the intervention group yielding more JA initiation during interaction with the preschool teachers. The effect generalized to significantly longer duration of JE with the mothers. Conclusions: This is the first randomized study to show positive and generalized effects of preschool-based JA-intervention. En ligne : http://dx.doi.org/10.1111/j.1469-7610.2011.02450.x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=148
in Journal of Child Psychology and Psychiatry > 53-1 (January 2012) . - p.97-105[article] A randomized controlled trial of preschool-based joint attention intervention for children with autism [Texte imprimé et/ou numérique] / Anett KAALE, Auteur ; Lars SMITH, Auteur ; Eili SPONHEIM, Auteur . - 2012 . - p.97-105.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 53-1 (January 2012) . - p.97-105
Mots-clés : Autism joint attention joint engagement intervention preschool randomized controlled trial Index. décimale : PER Périodiques Résumé : Background: Deficits in joint attention (JA) and joint engagement (JE) represent a core problem in young children with autism as these affect language and social development. Studies of parent-mediated and specialist-mediated JA-intervention suggest that such intervention may be effective. However, there is little knowledge about the success of the intervention when done in preschools. Aim: Assess the effects of a preschool-based JA-intervention. Methods: 61 children (48 males) with autistic disorder (29–60 months) were randomized to either 8 weeks of JA-intervention, in addition to their preschool programs (n = 34), or to preschool programs only (n = 27). The intervention was done by preschool teachers with weekly supervision by trained counselors from Child and Adolescent Mental Health Clinics (CAMHC). Changes in JA and JE were measured by blinded independent testers using Early Social Communication Scale (ESCS) and video taped preschool teacher–child and mother–child play at baseline and post-intervention. Clinical trials registration: Clinicaltrials.gov: NCT00378157. Results: Intention-to-treat analysis showed significant difference between the intervention and the control group, with the intervention group yielding more JA initiation during interaction with the preschool teachers. The effect generalized to significantly longer duration of JE with the mothers. Conclusions: This is the first randomized study to show positive and generalized effects of preschool-based JA-intervention. En ligne : http://dx.doi.org/10.1111/j.1469-7610.2011.02450.x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=148 Randomized controlled trial of a sibling support group: Mental health outcomes for siblings of children with autism / Emily A. JONES in Autism, 24-6 (August 2020)
[article]
Titre : Randomized controlled trial of a sibling support group: Mental health outcomes for siblings of children with autism Type de document : Texte imprimé et/ou numérique Auteurs : Emily A. JONES, Auteur ; Theresa FIANI, Auteur ; Jennifer L. STEWART, Auteur ; Nicole NEIL, Auteur ; Susan MCHUGH, Auteur ; Daniel M. FIENUP, Auteur Article en page(s) : p.1468-1481 Langues : Anglais (eng) Mots-clés : autism spectrum disorder mental health sibling adjustment support group typically developing siblings Index. décimale : PER Périodiques Résumé : Typically developing siblings of a child with autism spectrum disorder may show mental health difficulties. A support group is one approach to help typically developing siblings. During support groups, typically developing siblings discuss their feelings, learn coping strategies and problem-solving skills, and develop a peer network. We compared a support group to participation in a similar group without a focus on the sibling with autism spectrum disorder. Some areas of mental health improved. Improvements were also impacted by autism spectrum disorder symptom severity in the sibling with autism spectrum disorder. Findings suggest continuing to examine how support groups can help typically developing siblings and for which siblings support groups might be particularly effective. En ligne : http://dx.doi.org/10.1177/1362361320908979 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=428
in Autism > 24-6 (August 2020) . - p.1468-1481[article] Randomized controlled trial of a sibling support group: Mental health outcomes for siblings of children with autism [Texte imprimé et/ou numérique] / Emily A. JONES, Auteur ; Theresa FIANI, Auteur ; Jennifer L. STEWART, Auteur ; Nicole NEIL, Auteur ; Susan MCHUGH, Auteur ; Daniel M. FIENUP, Auteur . - p.1468-1481.
Langues : Anglais (eng)
in Autism > 24-6 (August 2020) . - p.1468-1481
Mots-clés : autism spectrum disorder mental health sibling adjustment support group typically developing siblings Index. décimale : PER Périodiques Résumé : Typically developing siblings of a child with autism spectrum disorder may show mental health difficulties. A support group is one approach to help typically developing siblings. During support groups, typically developing siblings discuss their feelings, learn coping strategies and problem-solving skills, and develop a peer network. We compared a support group to participation in a similar group without a focus on the sibling with autism spectrum disorder. Some areas of mental health improved. Improvements were also impacted by autism spectrum disorder symptom severity in the sibling with autism spectrum disorder. Findings suggest continuing to examine how support groups can help typically developing siblings and for which siblings support groups might be particularly effective. En ligne : http://dx.doi.org/10.1177/1362361320908979 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=428 Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder / Andrew W. ZIMMERMAN in Molecular Autism, 12 (2021)
[article]
Titre : Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : Andrew W. ZIMMERMAN, Auteur ; K. SINGH, Auteur ; S. L. CONNORS, Auteur ; H. LIU, Auteur ; Anita A PANJWANI, Auteur ; L. C. LEE, Auteur ; E. DIGGINS, Auteur ; A. FOLEY, Auteur ; S. MELNYK, Auteur ; I. N. SINGH, Auteur ; S. J. JAMES, Auteur ; R. E. FRYE, Auteur ; J. W. FAHEY, Auteur Article en page(s) : 38 p. Langues : Anglais (eng) Mots-clés : Autism spectrum disorder (ASD) Biomarkers Clinical trial Placebo effects Sulforaphane defendants in matters related to pediatric neurology and Autism Spectrum Disorder. JWF retired from the full-time faculty at Johns Hopkins in mid-2020, and now serves as a scientific advisor to Brassica Protection Products LLC (Baltimore, MD, USA), which produces a glucoraphanin-rich broccoli seed extract that it supplies to the supplement industry. AWZ is named on a patent on the use of sulforaphane for the treatment of autism that has been assigned to Johns Hopkins University. Index. décimale : PER Périodiques Résumé : BACKGROUND: Sulforaphane (SF), an isothiocyanate in broccoli, has potential benefits relevant to autism spectrum disorder (ASD) through its effects on several metabolic and immunologic pathways. Previous clinical trials of oral SF demonstrated positive clinical effects on behavior in young men and changes in urinary metabolomics in children with ASD. METHODS: We conducted a 15-week randomized parallel double-blind placebo-controlled clinical trial with 15-week open-label treatment and 6-week no-treatment extensions in 57 children, ages 3-12 years, with ASD over 36 weeks. Twenty-eight were assigned SF and 29 received placebo (PL). Clinical effects, safety and tolerability of SF were measured as were biomarkers to elucidate mechanisms of action of SF in ASD. RESULTS: Data from 22 children taking SF and 23 on PL were analyzed. Treatment effects on the primary outcome measure, the Ohio Autism Clinical Impressions Scale (OACIS), in the general level of autism were not significant between SF and PL groups at 7 and 15 weeks. The effect sizes on the OACIS were non-statistically significant but positive, suggesting a possible trend toward greater improvement in those on treatment with SF (Cohen's d 0.21; 95% CI -?0.46, 0.88 and 0.10; 95% CI -?0.52, 0.72, respectively). Both groups improved in all subscales when on SF during the open-label phase. Caregiver ratings on secondary outcome measures improved significantly on the Aberrant Behavior Checklist (ABC) at 15 weeks (Cohen's d -?0.96; 95% CI -?1.73, -?0.15), but not on the Social Responsiveness Scale-2 (SRS-2). Ratings on the ABC and SRS-2 improved with a non-randomized analysis of the length of exposure to SF, compared to the pre-treatment baseline (p?0.001). There were significant changes with SF compared to PL in biomarkers of glutathione redox status, mitochondrial respiration, inflammatory markers and heat shock proteins. Clinical laboratory studies confirmed product safety. SF was very well tolerated and side effects of treatment, none serious, included rare insomnia, irritability and intolerance of the taste and smell. LIMITATIONS: The sample size was limited to 45 children with ASD and we did not impute missing data. We were unable to document significant changes in clinical assessments during clinical visits in those taking SF compared to PL. The clinical results were confounded by placebo effects during the open-label phase. CONCLUSIONS: SF led to small yet non-statistically significant changes in the total and all subscale scores of the primary outcome measure, while for secondary outcome measures, caregivers' assessments of children taking SF showed statistically significant improvements compared to those taking PL on the ABC but not the SRS-2. Clinical effects of SF were less notable in children compared to our previous trial of a SF-rich preparation in young men with ASD. Several of the effects of SF on biomarkers correlated to clinical improvements. SF was very well tolerated and safe and effective based on our secondary clinical measures. TRIAL REGISTRATION: This study was prospectively registered at clinicaltrials.gov (NCT02561481) on September 28, 2015. Funding was provided by the U.S. Department of Defense. En ligne : http://dx.doi.org/10.1186/s13229-021-00447-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=459
in Molecular Autism > 12 (2021) . - 38 p.[article] Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder [Texte imprimé et/ou numérique] / Andrew W. ZIMMERMAN, Auteur ; K. SINGH, Auteur ; S. L. CONNORS, Auteur ; H. LIU, Auteur ; Anita A PANJWANI, Auteur ; L. C. LEE, Auteur ; E. DIGGINS, Auteur ; A. FOLEY, Auteur ; S. MELNYK, Auteur ; I. N. SINGH, Auteur ; S. J. JAMES, Auteur ; R. E. FRYE, Auteur ; J. W. FAHEY, Auteur . - 38 p.
Langues : Anglais (eng)
in Molecular Autism > 12 (2021) . - 38 p.
Mots-clés : Autism spectrum disorder (ASD) Biomarkers Clinical trial Placebo effects Sulforaphane defendants in matters related to pediatric neurology and Autism Spectrum Disorder. JWF retired from the full-time faculty at Johns Hopkins in mid-2020, and now serves as a scientific advisor to Brassica Protection Products LLC (Baltimore, MD, USA), which produces a glucoraphanin-rich broccoli seed extract that it supplies to the supplement industry. AWZ is named on a patent on the use of sulforaphane for the treatment of autism that has been assigned to Johns Hopkins University. Index. décimale : PER Périodiques Résumé : BACKGROUND: Sulforaphane (SF), an isothiocyanate in broccoli, has potential benefits relevant to autism spectrum disorder (ASD) through its effects on several metabolic and immunologic pathways. Previous clinical trials of oral SF demonstrated positive clinical effects on behavior in young men and changes in urinary metabolomics in children with ASD. METHODS: We conducted a 15-week randomized parallel double-blind placebo-controlled clinical trial with 15-week open-label treatment and 6-week no-treatment extensions in 57 children, ages 3-12 years, with ASD over 36 weeks. Twenty-eight were assigned SF and 29 received placebo (PL). Clinical effects, safety and tolerability of SF were measured as were biomarkers to elucidate mechanisms of action of SF in ASD. RESULTS: Data from 22 children taking SF and 23 on PL were analyzed. Treatment effects on the primary outcome measure, the Ohio Autism Clinical Impressions Scale (OACIS), in the general level of autism were not significant between SF and PL groups at 7 and 15 weeks. The effect sizes on the OACIS were non-statistically significant but positive, suggesting a possible trend toward greater improvement in those on treatment with SF (Cohen's d 0.21; 95% CI -?0.46, 0.88 and 0.10; 95% CI -?0.52, 0.72, respectively). Both groups improved in all subscales when on SF during the open-label phase. Caregiver ratings on secondary outcome measures improved significantly on the Aberrant Behavior Checklist (ABC) at 15 weeks (Cohen's d -?0.96; 95% CI -?1.73, -?0.15), but not on the Social Responsiveness Scale-2 (SRS-2). Ratings on the ABC and SRS-2 improved with a non-randomized analysis of the length of exposure to SF, compared to the pre-treatment baseline (p?0.001). There were significant changes with SF compared to PL in biomarkers of glutathione redox status, mitochondrial respiration, inflammatory markers and heat shock proteins. Clinical laboratory studies confirmed product safety. SF was very well tolerated and side effects of treatment, none serious, included rare insomnia, irritability and intolerance of the taste and smell. LIMITATIONS: The sample size was limited to 45 children with ASD and we did not impute missing data. We were unable to document significant changes in clinical assessments during clinical visits in those taking SF compared to PL. The clinical results were confounded by placebo effects during the open-label phase. CONCLUSIONS: SF led to small yet non-statistically significant changes in the total and all subscale scores of the primary outcome measure, while for secondary outcome measures, caregivers' assessments of children taking SF showed statistically significant improvements compared to those taking PL on the ABC but not the SRS-2. Clinical effects of SF were less notable in children compared to our previous trial of a SF-rich preparation in young men with ASD. Several of the effects of SF on biomarkers correlated to clinical improvements. SF was very well tolerated and safe and effective based on our secondary clinical measures. TRIAL REGISTRATION: This study was prospectively registered at clinicaltrials.gov (NCT02561481) on September 28, 2015. Funding was provided by the U.S. Department of Defense. En ligne : http://dx.doi.org/10.1186/s13229-021-00447-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=459 A randomized controlled trial of technology-enhanced behavioral parent training: sustained parent skill use and child outcomes at follow-up / Justin PARENT in Journal of Child Psychology and Psychiatry, 63-9 (September 2022)
[article]
Titre : A randomized controlled trial of technology-enhanced behavioral parent training: sustained parent skill use and child outcomes at follow-up Type de document : Texte imprimé et/ou numérique Auteurs : Justin PARENT, Auteur ; Margaret T. ANTON, Auteur ; Raelyn LOISELLE, Auteur ; April HIGHLANDER, Auteur ; Nicole BRESLEND, Auteur ; Rex FOREHAND, Auteur ; Megan HARE, Auteur ; Jennifer K. YOUNGSTROM, Auteur ; Deborah J. JONES, Auteur Article en page(s) : p.992-1001 Langues : Anglais (eng) Mots-clés : Attention Deficit and Disruptive Behavior Disorders/therapy Child Child Behavior Disorders/psychology/therapy Child, Preschool Follow-Up Studies Humans Parent-Child Relations Parenting/psychology Parents/education Technology Behavioral parent training child behavior disorders low-income families Index. décimale : PER Périodiques Résumé : BACKGROUND: Early-onset (3-8years old) disruptive behavior disorders (DBDs) have been linked to a range of psychosocial sequelae in adolescence and beyond, including delinquency, depression, and substance use. Given that low-income families are overrepresented in statistics on early-onset DBDs, prevention and early-intervention targeting this population is a public health imperative. The efficacy of Behavioral Parent Training (BPT) programs such as Helping the Noncompliant Child (HNC) has been called robust; however, given the additional societal and structural barriers faced by low-income families, family engagement and retention barriers can cause effects to wane with time. This study extends preliminary work by examining the potential for a Technology-Enhanced HNC (TE-HNC) program to improve and sustain parent skill proficiency and child outcomes among low-income families. METHODS: A randomized controlled trial with two parallel arms was the design for this study. A total of 101 children (3-8-years-old) with clinically significant problem behaviors from low-income households were randomized to HNC (n=54) or TE-HNC (n=47). Participants were assessed at pre-treatment, post-treatment, 3-month, and 6-month follow-ups. Primary outcomes were parent-reported and observed child behavior problems. Secondary outcomes included observed parenting skills use (ClinicalTrials.gov Identifier: NCT02191956). RESULTS: Primary analyses used latent curve modeling to examine treatment differences in the trajectory of change during treatment, maintenance of treatment gains, and levels of outcomes at the 6-month follow-up. Both programs yielded improvements in parenting skills and child problems at post-treatment. However, TE-HNC families evidenced greater maintenance of parent-reported and observed child behavior and observed positive parenting skills at the 6-month follow-up. CONCLUSIONS: Our findings contribute to an ongoing line of work suggesting that technology-enhanced treatment models hold promise for increasing markers of engagement in BPT and sustaining long-term outcomes among low-income families. En ligne : http://dx.doi.org/10.1111/jcpp.13554 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=486
in Journal of Child Psychology and Psychiatry > 63-9 (September 2022) . - p.992-1001[article] A randomized controlled trial of technology-enhanced behavioral parent training: sustained parent skill use and child outcomes at follow-up [Texte imprimé et/ou numérique] / Justin PARENT, Auteur ; Margaret T. ANTON, Auteur ; Raelyn LOISELLE, Auteur ; April HIGHLANDER, Auteur ; Nicole BRESLEND, Auteur ; Rex FOREHAND, Auteur ; Megan HARE, Auteur ; Jennifer K. YOUNGSTROM, Auteur ; Deborah J. JONES, Auteur . - p.992-1001.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 63-9 (September 2022) . - p.992-1001
Mots-clés : Attention Deficit and Disruptive Behavior Disorders/therapy Child Child Behavior Disorders/psychology/therapy Child, Preschool Follow-Up Studies Humans Parent-Child Relations Parenting/psychology Parents/education Technology Behavioral parent training child behavior disorders low-income families Index. décimale : PER Périodiques Résumé : BACKGROUND: Early-onset (3-8years old) disruptive behavior disorders (DBDs) have been linked to a range of psychosocial sequelae in adolescence and beyond, including delinquency, depression, and substance use. Given that low-income families are overrepresented in statistics on early-onset DBDs, prevention and early-intervention targeting this population is a public health imperative. The efficacy of Behavioral Parent Training (BPT) programs such as Helping the Noncompliant Child (HNC) has been called robust; however, given the additional societal and structural barriers faced by low-income families, family engagement and retention barriers can cause effects to wane with time. This study extends preliminary work by examining the potential for a Technology-Enhanced HNC (TE-HNC) program to improve and sustain parent skill proficiency and child outcomes among low-income families. METHODS: A randomized controlled trial with two parallel arms was the design for this study. A total of 101 children (3-8-years-old) with clinically significant problem behaviors from low-income households were randomized to HNC (n=54) or TE-HNC (n=47). Participants were assessed at pre-treatment, post-treatment, 3-month, and 6-month follow-ups. Primary outcomes were parent-reported and observed child behavior problems. Secondary outcomes included observed parenting skills use (ClinicalTrials.gov Identifier: NCT02191956). RESULTS: Primary analyses used latent curve modeling to examine treatment differences in the trajectory of change during treatment, maintenance of treatment gains, and levels of outcomes at the 6-month follow-up. Both programs yielded improvements in parenting skills and child problems at post-treatment. However, TE-HNC families evidenced greater maintenance of parent-reported and observed child behavior and observed positive parenting skills at the 6-month follow-up. CONCLUSIONS: Our findings contribute to an ongoing line of work suggesting that technology-enhanced treatment models hold promise for increasing markers of engagement in BPT and sustaining long-term outcomes among low-income families. En ligne : http://dx.doi.org/10.1111/jcpp.13554 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=486 Randomized Controlled Trial of the Focus Parent Training for Toddlers with Autism: 1-Year Outcome / Iris J. OOSTERLING in Journal of Autism and Developmental Disorders, 40-12 (December 2010)
PermalinkA Randomized Controlled Trial of the Korean Version of the PEERS® Parent-Assisted Social Skills Training Program for Teens With ASD / Hee-Jeong YOO in Autism Research, 7-1 (February 2014)
PermalinkA Randomized Controlled Trial of the Social Tools And Rules for Teens (START) Program: An Immersive Socialization Intervention for Adolescents with Autism Spectrum Disorder / Ty W. VERNON in Journal of Autism and Developmental Disorders, 48-3 (March 2018)
PermalinkRandomized Controlled Trial of a Video Gaming-Based Social Skills Program for Children on the Autism Spectrum / Renae BEAUMONT in Journal of Autism and Developmental Disorders, 51-10 (October 2021)
PermalinkRandomized controlled trial of vitamin D supplementation in children with autism spectrum disorder / Khaled SAAD in Journal of Child Psychology and Psychiatry, 59-1 (January 2018)
PermalinkA randomized controlled trial to examine the effects of the Tackling Teenage psychosexual training program for adolescents with autism spectrum disorder / Kirsten VISSER in Journal of Child Psychology and Psychiatry, 58-7 (July 2017)
PermalinkA Randomized Controlled Trial to Improve Social Skills in Young Adults with Autism Spectrum Disorder: The UCLA PEERS® Program / Elizabeth A. LAUGESON in Journal of Autism and Developmental Disorders, 45-12 (December 2015)
PermalinkA randomized controlled trial to test the effectiveness of a peer-based social mobile game intervention to reduce smoking in youth / H. SCHOLTEN in Development and Psychopathology, 31-5 (December 2019)
PermalinkA randomized cross-over trial investigating the neurocognitive effects of acute exercise on face recognition in children with autism spectrum disorder / Sebastian LUDYGA in Autism Research, 16-8 (August 2023)
PermalinkA randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome / A. LIGSAY in Journal of Neurodevelopmental Disorders, 9-1 (December 2017)
Permalink